|« Previous month||Next month »|
31-Jan-2012 - in-PharmaTechnologist presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Sirona, Hospira, and Biogen Idec.
31-Jan-2012 - DSM Pharmaceutical Products (DPP) will sell APIs made by Indian manufacturer Indoco Remedies in a new agreement that fits with its global expansion plan.
31-Jan-2012 - Ingredient maker Dishman Pharmaceuticals has confirmed that it may offload its Chinese API (active pharmaceutical ingredients) factory.
31-Jan-2012 - Cephalon is recalling a single lot of leukaemia treatment Treanda after glass fragments were found in a vial.
31-Jan-2012 - The FDA has hit Novartis with another 483 after finding seven repeat observations and a backlog of 1,360 overdue consumer complaints.
30-Jan-2012 - BASF has hiked its prices for ethanolamines just days after asking the European Commission to review measures designed to stop US exporters selling the compound at less than cost to...
30-Jan-2012 - Patheon will focus its upcoming growth efforts on solubility enhancing tech after receiving an influx of requests from clients.
30-Jan-2012 - The FDA has updated its question and answer document to help manufacturers of topical antiseptics prevent contamination.
30-Jan-2012 - Zogenix is collaborating with Battelle to out-license its needle-free drug delivery technology, DosePro.
27-Jan-2012 - Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.
26-Jan-2012 - in-PharmaTechnologist presents a round-up of issues within the pharmaceutical manufacturing industry, including Novartis’ plans to restart Nebraska ops and problems for Roche at it’s South Carolina facility.
26-Jan-2012 - The US has filed a “groundbreaking” injunction against Ranbaxy to force the generic giant to make “fundamental changes” at its plants.
26-Jan-2012 - Simplification of French tax laws would incentivise Pharmas to manufacture drugs in the country according to a government advisory body.
26-Jan-2012 - Europe is considering forcing API manufacturers to verify the source of starting materials as part of GMP revisions.
25-Jan-2012 - in-PharmaTechnologist presents its round-up of the latest manufacturing headlines including new facilities for Aptar and Granules, and some good news for Swiss Novartis workers.
25-Jan-2012 - Ibuprofen API maker Albemarle says favourable volumes and pricing helped drive gains made by fine chemicals unit in Q4.
25-Jan-2012 - Vivalis nearly doubled revenues from its vaccine production platform in 2011 and has inked a third mAb discovery programme with Sanofi.
25-Jan-2012 - Ashland is investing in production assets and raising prices as it looks to get the most from its $3.2bn acquisition.
24-Jan-2012 - in-PharmaTechnololist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Prosonix, GENO, and BioCryst.
24-Jan-2012 - Granules India says Big Pharma demand for highly efficient manufacturing in era of patent loss helped it gain market share in Q3 fiscal 2012.
24-Jan-2012 - The FDA has followed the EMA in approving the Framingham, MA plant that Genzyme hopes will cut production bottlenecks.
24-Jan-2012 - PolyPid plans to begin clinical development of its novel lipid-polymer fusion-based drug delivery technology with new through a new financing round.
24-Jan-2012 - Sartorius Stedim Biotech (SSB) says its partnership with Refine Technology will help meet demand for greater connectivity between retention devices and bioreactors and save Pharmas time and money
23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.
23-Jan-2012 - Alnylam is cutting its headcount by one-third to lower operating costs as it attempts to bring an RNAi product to market.
|« Previous month||Next month »|